Neurophth Biotechnology picks up $61.9m Series B
Neurophth Biotechnology Ltd., a genetic medicines company, has raised $61.9 million in Series B financing.
Neurophth Biotechnology Ltd., a genetic medicines company, has raised $61.9 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
